Lakefront Biotherapeutics NV Operating Expenses Growth & History (LKFT)

Lakefront Biotherapeutics NV's operating expenses was €787.5M for fiscal 2025.

View full Lakefront Biotherapeutics NV company overview

Lakefront Biotherapeutics NV annual operating expenses history

Lakefront Biotherapeutics NV annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31€787.5M€358.3M+83.51%
20242024-12-31€429.1M€101.1M+30.84%
20232023-12-31€328.0M−€32.2M−8.95%
20222022-12-31€360.2M−€44.1M−10.91%
20212021-12-31€404.3M−€304.6M−42.96%
20202020-12-31€708.9M€191.8M+37.10%
20192019-12-31€517.0M€162.3M+45.75%
20182018-12-31€354.7M€109.0M+44.37%
20172017-12-31€245.7M€82.6M+50.65%
20162016-12-31€163.1M€13.1M+8.72%
20152015-12-31€150.0M

Lakefront Biotherapeutics NV operating expenses trends

Over the last five fiscal years, Lakefront Biotherapeutics NV's operating expenses increased from €708.9M to €787.5M, a change of €78.6M. The latest reported quarter, Q2 2026, shows €46.5M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Lakefront Biotherapeutics NV source filings ↗

Community posts

It’s quiet here.

No posts about LKFT yet. Start the conversation.

Write the first post